FIG 5.
Protection against cerebral toxoplasmosis in pVAX-CDPK5-immunized mice and controls after challenge with 10 tissue cysts of the T. gondii PRU strain 2 weeks after the last booster immunization. **, statistically significant difference (P = 0.005).